跳至主要内容
临床试验/NCT05801900
NCT05801900尚未招募不适用

Intravenous Ibuprofen Versus Ketorolac for Perioperative Pain Control in Morbid Obese Patients Undergoing Bariatric Surgery: a Randomized Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2023年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
116
试验地点
1
主要终点
VAS

研究概览

简要总结

The aim of the current study is to compare the analgesic effects of both drugs in patients with obesity undergoing bariatric surgery.

详细描述

Upon arrival to the operating room, routine monitors (electrocardiogram, pulse oximetry, and non-invasive blood pressure monitor) will be applied; intravenous line will be secured, and prophylactic antiemetic will be provided in the form of slow intravenous injection of 5 mg dexamethasone drugs.

Anesthesia Anesthesia will be induced with 2 mg/kg propofol, 2 mcg/kg fentanyl (lean body weight), and tracheal intubation will be facilitated by 0.6 mg/kg ideal body weight rocuronium after loss of consciousness. Anesthesia will be maintained with isoflurane 1-1.2% in oxygen and 0.1 mg/kg rocuronium every 30 minutes. Fentanyl boluses of 1 mcg/kg will be given if heart rate or/and systolic blood pressure >120% of baseline.

Postoperatively, pain assessments using the visual analogue scale (VAS) will be performed at rest and during movement (knee flexion) at 0.5, 4, 10, 18, and 24 h after leaving the operating room. If the VAS score is > 3 intravenous nalbuphine 0.1-0.2 mg/kg (lean body weight) titrated to response with maximum single dose of 20 mg and maximum daily dose of 160 mg.

Intravenous ondansetron 4 mg will be given to treat postoperative nausea or vomiting

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult (18-65 years) patients
  • body mass index ≥35 kg/m2
  • scheduled for laparoscopic bariatric surgery

排除标准

  • American Society of Anesthesiologists (ASA) physical class IV,
  • severe cardiac comorbidity (impaired contractility with ejection fraction < 50%, heart block, significant arrhythmias, tight valvular lesions),
  • known obstructive sleep apnea or patients with STOP-bang score ≥5,
  • baseline SpO2 <95%,
  • renal impairment,
  • allergy to any of study's drugs,
  • history of gastrointestinal bleeding or ulceration, or inflammatory bowel disease

研究组 & 干预措施

Ketorolac group

Active Comparator

ketorolac 30 mg (diluted in 200 mL normal saline) intravenously over 5 minutes

干预措施: Ketorolac group (Drug)

Ibuprofen group

Active Comparator

ibuprofen 800 mg intravenously (Diluted in 200 mL of normal saline) over 5 minutes

干预措施: Ibuprofen group (Drug)

结局指标

主要结局

VAS

时间窗: 30 minutes after extubation

Visual analogue scale

次要结局

  • total intraoperative fentanyl(30 seconds after skin incision until 1 min after skin closure)
  • post operative nalbuphine(30 minutes after extubation until 24 hours postoperatively)
  • VAS(at 0.5, 4, 10, 18, and 24 hours after extubation)
  • time to independent movement(30 minutes after extubation until 24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Hasanin

Principal Investigator

Cairo University

研究点 (1)

Loading locations...

相似试验